Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

A. H. Sims, A. J. M. Zweemer, Y. Nagumo, D. Faratian, M. Muir, M. Dodds, I. Um, C. Kay, M. Hasmann, D. J. Harrison, S. P. Langdon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science